Patterns of transcription factor programs and immune pathway activation define four major subtypes of SCLC with distinct therapeutic vulnerabilities.

Journal:
Cancer Cell
Published:
DOI:
10.1016/j.ccell.2020.12.014
Affiliations:
10
Authors:
30
Institutions Authors Share
The University of Texas MD Anderson Cancer Center, United States of America (USA)
22.000000
22.000000
22.000000
0.73
Vanderbilt University Medical Center (VUMC), United States of America (USA)
2.000000
0.07
Genentech, Inc., United States of America (USA)
2.000000
0.07
AstraZeneca United States, United States of America (USA)
1.000000
0.03
University of Campania Luigi Vanvitelli, Italy
1.000000
0.03
The Jackson Laboratory (JAX), United States of America (USA)
1.000000
0.03
The University of Texas Southwestern Medical Center (UT Southwestern Medical Center), United States of America (USA)
1.000000
0.03